dm+d
82573000
Articles
Lidocaine 10mg/ml spray for IUC insertion or removal
19 January 2023
SPS protocol template for administration of lidocaine 10mg/ml spray to facilitate intrauterine contraception (IUC) insertion or removal.Lidocaine plus prilocaine cream for IUC insertion or removal
19 January 2023
SPS protocol template for the administration of lidocaine plus prilocaine cream to facilitate intrauterine contraception (IUC) insertion or removal.Lidocaine products: information for supporting intrathecal risk assessment
11 August 2022
Lidocaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administrationCeftriaxone intramuscular injection for Neisseria gonorrhoeae
5 October 2021
SPS PGD template for administering ceftriaxone injection (with lidocaine) by IM injection for treating uncomplicated Neisseria gonorrhoeae infection.Lidocaine injection for subdermal etonogestrel in contraception
4 October 2021
SPS PGD template for administering lidocaine injection to facilitate insertion and/or removal of subdermal etonogestrel (e.g. Nexplanon®) implants.Lactation Safety Information
Intravenous
as anti-arrhythmic
Intravenous
as anti-arrhythmic
-
Small amounts in breast milk
Moderate published evidence of use in breastfeeding
Minimal absorption from the infant’s GI tract
Used in full-term neonates from birth
30 July 2020
For local anaesthesia
For local anaesthesia
Limited published evidence of safety
This entry applies to all uses (infiltration, regional and surface anaesthesia and nerve blocks) and formulations (injection/topical) of lidocaine for local anaesthesia, including injections with adrenaline
Small amounts in breast milk and minimal absorption from the infant’s GI tract
30 July 2020
For ophthalmic use
For ophthalmic use
Only available in combination with fluorescein for which there are no additional risks
30 July 2020
Ointment/spray for orophayngeal use
Ointment/spray for orophayngeal use
30 July 2020
Rectal
Rectal
-
Topical/rectal use for short periods in combination with a corticosteroid considered to present minimal risk to breastfed infant
30 July 2020